Physician

Richard Andrew Krathen, MD.

According to 2025 Medicare claims, Richard Krathen, MD. (NPI: 1013962638) practices dermatology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from Martin, FL. This provider's primary affiliated billing organization is FLORIDA DERMATOLOGY SPECIALISTS, PLLC (NPI: 1164140521; TIN: 87-3842132) and primary practice location at 34997-5556.

Krathen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,012 traditional Medicare patients, billed 19,879 HCPCS/CPT codes, and received $1,965,703 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 758 prescription claims across 386 beneficiaries totaling $20,729 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 4 records totaling $90. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $989,368 to $1,965,703. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $108,713 and ending at $20,729. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,909	16,133	$989,368
2016	1,940	17,163	$1,079,137
2017	1,911	16,711	$1,038,099
2018	1,941	17,834	$1,127,732
2019	2,044	19,103	$1,239,973
2020	1,844	18,767	$1,322,127
2021	1,936	19,637	$1,535,776
2022	1,877	18,784	$1,482,137
2023	1,676	16,835	$1,454,071
2024	2,012	19,879	$1,965,703

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	454	813	$108,713
2016	457	822	$72,309
2017	466	876	$131,089
2018	534	1,021	$248,544
2019	588	1,177	$290,669
2020	562	1,196	$67,098
2021	604	1,321	$157,348
2022	537	1,061	$121,339
2023	397	774	$27,360
2024	386	758	$20,729

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	1,116	1,534	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,448	2,395	$64
11103	Biopsy of related skin growth, each additional growth	532	1,129	$39
17000	Destruction of precancer skin growth, 1 growth	1,218	1,826	$36
17003	Destruction of precancer skin growth, 2-14 growths	965	7,463	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	103	2,978	$5,130
Ketoconazole	Ketoconazole	155	4,479	$1,991
Fluorouracil	Fluorouracil	24	804	$1,856
Metronidazole	Metronidazole	39	1,165	$1,712
Doxycycline Hyclate	Doxycycline Hyclate	36	1,940	$1,471

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$90	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard Andrew Krathen, MD.?

Tedicare shows public-source Medicare data for Richard Andrew Krathen, MD. (NPI 1013962638), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Andrew Krathen, MD. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard Andrew Krathen, MD.?

Richard Andrew Krathen, MD. is linked to FLORIDA DERMATOLOGY SPECIALISTS, PLLC (billing NPI 1164140521) in the available physician profile data.

Does Richard Andrew Krathen, MD. have Open Payments data?

Richard Andrew Krathen, MD. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.